Team:UCSF/SandBox

From 2010.igem.org

(Difference between revisions)
 
(37 intermediate revisions not shown)
Line 2: Line 2:
<style>
<style>
body{
body{
-
background-color:#494d51;
+
//background-color:white;//#494d51;
}
}
h1{
h1{
Line 14: Line 14:
text-indent: 10px;
text-indent: 10px;
}
}
-
p, pre{
+
#left p, #left pre{
margin-left:35px;
margin-left:35px;
margin-right:35px;
margin-right:35px;
Line 21: Line 21:
text-align:justify;
text-align:justify;
}
}
-
h3{
+
#left h3{
font-weight:normal;
font-weight:normal;
text-vertical-align:middle;
text-vertical-align:middle;
Line 38: Line 38:
}
}
div#top-section{
div#top-section{
-
background-color:#3683D3;
+
background-color:#FF535D;
-
width:971px;
+
width:959px;
height: 24px;
height: 24px;
border:none;
border:none;
Line 57: Line 57:
     //display: none;
     //display: none;
     //text-indent:10px;
     //text-indent:10px;
-
     top: 0;
+
     top: 0px;
 +
    color:black;
}
}
 +
div#p-logo{
div#p-logo{
     display: none;
     display: none;
Line 68: Line 70:
}
}
#content{
#content{
 +
background-image:url(https://static.igem.org/mediawiki/2010/4/45/UCSF_DropShadow.png);
 +
background-repeat:vertical;
margin-top:-24px;
margin-top:-24px;
-
padding-left:2px;
+
padding-left:8px;
-
padding-right:2px;
+
border:none;
 +
padding-right:8px;
padding-top:2px;
padding-top:2px;
z-index:0;
z-index:0;
-
width:971px;
+
width:959px;
}
}
 +
#footer-box{
 +
background-image:url(https://static.igem.org/mediawiki/2010/d/df/UCSF_FooterDropShadow.png);
 +
background-position:center bottom;
 +
background-repeat:no-repeat;
 +
width:955px;
 +
padding-left:10px;
 +
padding-right:10px;
 +
padding-bottom:10px;
 +
border:none;
 +
margin-bottom:24px;
 +
}
 +
#navigation ul,
#navigation ul,
#navigation li{
#navigation li{
Line 225: Line 242:
#banner{
#banner{
margin-top:24px;
margin-top:24px;
-
width:971px;
+
width:957px;
overflow:hidden;
overflow:hidden;
margin-left:auto;
margin-left:auto;
Line 231: Line 248:
}
}
#Main{
#Main{
-
width:971px;
+
width:959px;
overflow:hidden;
overflow:hidden;
margin-top:2px;
margin-top:2px;
margin-left:auto;
margin-left:auto;
margin-right:auto;
margin-right:auto;
-
height:100%;
 
}
}
</style>
</style>
Line 245: Line 261:
</html>
</html>
{{Template:UCSF/Nav}}
{{Template:UCSF/Nav}}
 +
<html>
<html>
-
<style>
 
-
#left{
 
-
margin-top:-10px;
 
-
float:left;
 
-
width:723px;
 
-
background-color:#EFEFED;
 
-
}
 
-
</style>
 
-
 
<style type="text/css">
<style type="text/css">
.searchform {
.searchform {
Line 305: Line 313:
</style>
</style>
 +
<table border="0" style="margin:0px;padding:0px;margin-top:-25px;">
 +
<tbody>
 +
<tr>
 +
<td width="707px" style="padding: 0 0 0 0; background-color:#ede8e2;margin:0;" valign="top">
-
<div id="left">
+
<div id="left" style="width:100%;height:100%;">
-
 
+
-
 
+
</html>
</html>
===Project Description===
===Project Description===
Line 315: Line 325:
Our team will focus on improving NK cells’ specificity and killing efficiency towards certain cancer types. By using synthetic biology tools and logic gates’ design, we hope to create powerful killing biomachines for the fight against cancer. Our newly engineered synthetic devices would have the potential to enhance current adoptive cell-based immunotherapy for cancer patients.
Our team will focus on improving NK cells’ specificity and killing efficiency towards certain cancer types. By using synthetic biology tools and logic gates’ design, we hope to create powerful killing biomachines for the fight against cancer. Our newly engineered synthetic devices would have the potential to enhance current adoptive cell-based immunotherapy for cancer patients.
-
 
-
{{Template:UCSF/LeftEnd}}
 
<html>
<html>
-
<style>
+
</div>
-
#right{
+
</td>
-
margin-top:-10px;
+
</html>
-
float:right;
+
<html>
-
width:248px;
+
<td width="250px" style="padding: 0 0 0 0; background-color:#d8d5d0;margin:0;" valign="top">
-
background-color:#C5C5C5;
+
<div id="right" style="width:100%;height:100%;">
-
height:100%;
+
-
}
+
-
</style>
+
-
<div id="right">
+
<form class="searchform" method="get" action="http://www.google.com/search">
<form class="searchform" method="get" action="http://www.google.com/search">
Line 340: Line 344:
'''RIGHT CONTENT'''<br>
'''RIGHT CONTENT'''<br>
replace this area with your content.
replace this area with your content.
-
{{Template:UCSF/RightEnd}}
+
<html>
 +
</div>
 +
</td>
 +
</tr>
 +
</tbody>
 +
</table>
 +
<div style="border-bottom:1px black dashed;height:10px;"></div>
 +
</div>
 +
<script>
 +
var list = Numbering.split(" ");
 +
for(var i=0;i<list.length;i++){
 +
var Item = document.getElementById(list[i]);
 +
var cn = Item.className;
 +
Item.className=cn+" active";
 +
}
 +
</script>
 +
</html>
__NOTOC__
__NOTOC__

Latest revision as of 14:25, 26 October 2010


Project Description

Natural killer (NK) cells of the immune system identify cancer and virally-infected cells and kill them. These potent killers travel throughout the body, recognizing proteins and other molecules on the surface of cells. In order to differentiate between healthy and diseased cells, NK cells use a variety of receptors, which bind to specific ligands at the target cells’ surface. The balance between activating and inhibitory signals will tell the NK cell if the target cell is diseased or healthy, respectively. If the target cell is deemed potentially dangerous, the NK cell grips the target cell tightly and creates an immunological synapse at the site of adhesion. Within this immunological synapse, the NK cell releases cytotoxic granules to kill the target cell without harming any nearby cells allowing for a direct, apoptotic death.

Our team will focus on improving NK cells’ specificity and killing efficiency towards certain cancer types. By using synthetic biology tools and logic gates’ design, we hope to create powerful killing biomachines for the fight against cancer. Our newly engineered synthetic devices would have the potential to enhance current adoptive cell-based immunotherapy for cancer patients.

Retrieved from "http://2010.igem.org/Team:UCSF/SandBox"